rs35953626

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_153717.3(EVC):​c.1328G>A​(p.Arg443Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0128 in 1,614,078 control chromosomes in the GnomAD database, including 2,137 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. R443R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.067 ( 1127 hom., cov: 34)
Exomes 𝑓: 0.0072 ( 1010 hom. )

Consequence

EVC
NM_153717.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:13

Conservation

PhyloP100: 0.112

Publications

11 publications found
Variant links:
Genes affected
EVC (HGNC:3497): (EvC ciliary complex subunit 1) This gene encodes a protein containing a leucine zipper and a transmembrane domain. This gene has been implicated in both Ellis-van Creveld syndrome (EvC) and Weyers acrodental dysostosis. [provided by RefSeq, Jul 2008]
CRMP1 (HGNC:2365): (collapsin response mediator protein 1) This gene encodes a member of a family of cytosolic phosphoproteins expressed exclusively in the nervous system. The encoded protein is thought to be a part of the semaphorin signal transduction pathway implicated in semaphorin-induced growth cone collapse during neural development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0012990832).
BP6
Variant 4-5753797-G-A is Benign according to our data. Variant chr4-5753797-G-A is described in ClinVar as Benign. ClinVar VariationId is 5342.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.223 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EVCNM_153717.3 linkc.1328G>A p.Arg443Gln missense_variant Exon 10 of 21 ENST00000264956.11 NP_714928.1 P57679

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EVCENST00000264956.11 linkc.1328G>A p.Arg443Gln missense_variant Exon 10 of 21 1 NM_153717.3 ENSP00000264956.6 P57679
EVCENST00000509451.1 linkc.1328G>A p.Arg443Gln missense_variant Exon 10 of 12 1 ENSP00000426774.1 E9PCN4
EVCENST00000514919.1 linkn.391G>A non_coding_transcript_exon_variant Exon 2 of 2 2
CRMP1ENST00000506216.5 linkn.1648-5485C>T intron_variant Intron 12 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.0665
AC:
10108
AN:
152114
Hom.:
1122
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.226
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0345
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00131
Gnomad OTH
AF:
0.0555
GnomAD2 exomes
AF:
0.0176
AC:
4418
AN:
251456
AF XY:
0.0129
show subpopulations
Gnomad AFR exome
AF:
0.232
Gnomad AMR exome
AF:
0.0124
Gnomad ASJ exome
AF:
0.000595
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00104
Gnomad OTH exome
AF:
0.0119
GnomAD4 exome
AF:
0.00720
AC:
10530
AN:
1461846
Hom.:
1010
Cov.:
30
AF XY:
0.00626
AC XY:
4549
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.235
AC:
7864
AN:
33476
American (AMR)
AF:
0.0141
AC:
630
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000383
AC:
10
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000580
AC:
50
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.0141
AC:
81
AN:
5756
European-Non Finnish (NFE)
AF:
0.000769
AC:
855
AN:
1111994
Other (OTH)
AF:
0.0172
AC:
1039
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
541
1082
1623
2164
2705
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0666
AC:
10140
AN:
152232
Hom.:
1127
Cov.:
34
AF XY:
0.0643
AC XY:
4787
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.226
AC:
9401
AN:
41512
American (AMR)
AF:
0.0344
AC:
527
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00129
AC:
88
AN:
68028
Other (OTH)
AF:
0.0549
AC:
116
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
407
815
1222
1630
2037
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0274
Hom.:
1068
Bravo
AF:
0.0778
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.225
AC:
991
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.0210
AC:
2553
Asia WGS
AF:
0.0150
AC:
54
AN:
3478
EpiCase
AF:
0.000927
EpiControl
AF:
0.00184

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 11, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 16, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Ellis-van Creveld syndrome Uncertain:1Benign:3
Sep 12, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 01, 2000
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

May 18, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 30, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Curry-Hall syndrome Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
12
DANN
Benign
0.93
DEOGEN2
Benign
0.082
T;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.099
N
LIST_S2
Benign
0.75
T;T
MetaRNN
Benign
0.0013
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L;.
PhyloP100
0.11
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.53
N;N
REVEL
Benign
0.058
Sift
Benign
0.71
T;T
Sift4G
Benign
0.80
T;T
Polyphen
0.27
B;.
Vest4
0.079
ClinPred
0.0067
T
GERP RS
1.1
Varity_R
0.042
gMVP
0.049
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35953626; hg19: chr4-5755524; COSMIC: COSV53834162; API